Stories indexed under: Technology transfer

Total: 19   RSSRSS feed

  • Wisconsin technology powers California microgrid project March 21, 2012 California’s Santa Rita Jail just got a little more secure this week, thanks to the completion of a $14 million “microgrid” project that gives the facility its own autonomous power supply — a feat rooted in University of Wisconsin-Madison technology.
  • UW–Madison hosts Iraqi economic development delegation Oct. 19, 2011 The University of Wisconsin-Madison is one of two American universities to host a delegation of representatives selected by Iraq's Inter-Ministerial Committee on Innovation, Research, and Development (ICIRD) on universities and technology-based economic development.
  • Breakthrough device to debut at National Eye Institute’s 40th anniversary kickoff event March 25, 2009 A portable vision device that provides blind individuals sensory input similar to vision will be presented at the 40th anniversary celebration for the National Eye Institute, part of the National Institutes of Health, on Friday, April 3.
  • Course builds community of biomedical entrepreneurs Feb. 16, 2009 A new multidisciplinary course at the University of Wisconsin-Madison is preparing entrepreneurial graduate students to bring biomedical innovations to the patients who need them.
  • All NIH human embryonic stem cell registry lines now deposited at NSCB Jan. 12, 2009 The U.S. National Stem Cell Bank (NSCB) has announced that it has received deposits of two human embryonic stem cell lines from Cellartis AB, a biotechnology company based in Sweden. With the addition of the new lines, the National Stem Cell Bank now has received all 21 cell lines from the six providers listed on the National Institutes of Health (NIH) federal registry.
  • VistaGen, WARF sign license agreement for human embryonic stem cell technology Dec. 18, 2008 VistaGen Therapeutics and the Wisconsin Alumni Research Foundation (WARF) have signed a license for human embryonic stem cell patents for the development and commercialization of stem cell-based research tools.
  • Photo of lab vial WiCell Research Institute launches new stem cell bank Aug. 21, 2008 The WiCell Research Institute, a private, not-for-profit supporting organization to the University of Wisconsin-Madison, is launching its own stem cell bank to distribute cell lines beyond the 21 lines eligible for federal funding and distribution through the National Stem Cell Bank (NSCB).
  • Part of architectural floor plan New ‘urban research park’ offers jolt of electricity to Madison high-tech startups Aug. 4, 2008 After three decades of almost exponential commercial growth on Madison's west side, the University Research Park (URP) will pursue an opportunity to sink roots downtown with an innovative "urban research park" targeting high-technology entrepreneurs.
  • Photo of airless tire Airless tire project may prove a lifesaver in military combat June 26, 2008 An ambitious startup company in Wausau is working on a project to develop tires that can withstand extreme punishment, even those meted out in military combat zones.
  • Photo of asphalt sample Green highways: Research targets environmentally friendly asphalts May 27, 2008 For those hoping to create a greener world, our country's millions of miles of asphalt roads may seem like an odd place to seek solutions. Yet, it's precisely because asphalt is so common that we have much to gain from making it more eco-friendly, says University of Wisconsin-Madison civil engineering professor Hussain Bahia.
  • Invitrogen, WARF sign license agreement for human embryonic stem cells May 8, 2008 Invitrogen Corp. and the Wisconsin Alumni Research Foundation announced today (May 8) that they have signed a license for human embryonic stem cell (hESC) patents for the development of research tools.
  • WARF licenses influenza vaccine technology to FluGen May 8, 2008 The Wisconsin Alumni Research Foundation and FluGen have signed license agreements for a technology that has the potential to significantly improve the way influenza vaccines are manufactured.
  • Roche NimbleGen CEO Stan Rose to speak on exit strategies for start-up companies April 24, 2008 Stan Rose, president and CEO of Roche NimbleGen, a manufacturer of gene chips for pharmaceutical research, will speak about successful exit strategies for start-up companies on Monday, April 28 at 5 p.m. at the Fluno Center, 601 University Avenue. The event is free and open to the public as part of the Gilson Discovery Series hosted by the Wisconsin Alumni Research Foundation (WARF).
  • TomoTherapy’s Mackie to speak on faculty entrepreneurship March 28, 2008 Thomas Rockwell Mackie, co-founder, chairman of the board and director of research at TomoTherapy, will speak on faculty entrepreneurship on Wednesday, April 2, beginning at 5 p.m. The event, part of the Gilson Discovery Series hosted by the Wisconsin Alumni Research Foundation, is free and open to the public.
  • Talk commemorates 75th anniversary of Warfarin saga Jan. 25, 2008 Seventy-five years ago this February, a Wisconsin dairy farmer brought some sweet clover hay to University of Wisconsin-Madison biochemist Karl Paul Link. The farmer suspected the clover had killed his cattle, which died from uncontrollable bleeding. From one farmer's misfortune, much good has come.
  • California company licenses WARF stem cell technology Jan. 9, 2008 BioTime, Inc. (OTCBB: BTIM) has signed a licensing agreement with the Wisconsin Alumni Research Foundation (WARF) for 173 patents and patent applications relating to human embryonic stem cell technology created by James Thomson at the University of Wisconsin-Madison.
  • WARF announces new hires and promotions Oct. 1, 2007 The Wisconsin Alumni Research Foundation (WARF) has announced promotions for Michael E. Falk and Emily Bauer, and the hires of a communications director, Janet L. Kelly, and two licensing professionals, Craig Heim for start-up companies, and Mark Stoveken for pharmaceutical licensing.
  • Woman looking through microscope Basic research robust in face of more university patenting Sept. 10, 2007 A UW-Madison study of more than 1,800 U.S. life scientists found that, despite an explosion in academic patenting in recent years, most life science professors still do research the "old-fashioned" way: they win federal grants, publish results in scientific journals, and graduate Ph.D. students.
  • State seeds stem-cell company based on UW-Madison research May 14, 2007 Governor Jim Doyle today (May 14) gave a $1 million boost to a University of Wisconsin-Madison spin-off company during a visit to the campus lab that gave birth to its technology.